BlackRock Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $179K | Buy |
56,974
+14,020
| +33% | +$44K | ﹤0.01% | 2680 |
|
|
2016
Q3 | $146K | Hold |
42,954
| – | – | ﹤0.01% | 2714 |
|
|
2016
Q2 | $98K | Hold |
42,954
| – | – | ﹤0.01% | 2787 |
|
|
2016
Q1 | $108K | Buy |
42,954
+36,270
| +543% | +$91.2K | ﹤0.01% | 2725 |
|
|
2015
Q4 | $22K | Hold |
6,684
| – | – | ﹤0.01% | 2920 |
|
|
2015
Q3 | $16K | Buy |
+6,684
| New | +$16K | ﹤0.01% | 2986 |
|